ATTORNEY NEWSLETTER A large Indian pharmaceutical manufacturer has agreed to settle with the United States and states’ attorneys general in a whistleblower lawsuit. The pharmaceutical manufacturer was alleged to have...
Archives
ATTORNEY NEWSLETTER In the past, the Food and Drug Administration (FDA) took the lead role in investigating pharmaceutical manufacturing facilities for violations of good manufacturing practices (cGMP’s). Recently,...
Fresenius Medical Care’s Acid Concentrates Causes High Cardiac Risk on Dialysis Patients
April 24, 2013
– ATTORNEY NEWSLETTER – The Food and Drug Administration recalled two powerful acid concentrates in March of 2012. Both products, GranuFlo, a powder-based concentrate, and Naturalyte, a liquid-based concentrate,...
Biotechnological Company Pays $2.9 Million Settlement
April 17, 2013
– ATTORNEY NEWSLETTER – Amgen, Inc., a California-based biotechnology company, agrees to pay a $2.9 million settlement after allegations of marketing their products to patients who did...
ATTORNEY NEWSLETTER A CVS subsidiary group – RxAmerica – will pay a $5.25 million settlement in response to false claims allegations against Medicare. Two related complaints were brought on behalf of the U.S. government...